Scholars Central

Conference abstractPublished 2015

Mining the A. nidulans metabolome for tau aggregation inhibitors

Authors: T Chris Gamblin, S R Paranjape, Y M Chiang, C Wang, B R Oakley, T C Gamblin

University of Kansas, USA University of Southern California, USA Chia Nan University of Pharmacy and Science, Taiwan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The abnormal aggregation of the microtubule-associated protein tau is believed to result in cell death and cognitive deficits in Alzheimer’s disease and several other neurodegenerative diseases. The inhibition and reversal of tau aggregation would likely have therapeutic benefit for the treatment of such disorders. In our efforts to identify tau aggregation inhibitors (TAIs), we have sought to mine the secondary metabolome of the fungus Aspergillus nidulans for unique compounds with antiaggregation properties. Fungal natural products have historically been a rich source of biologically important compounds ranging from anti-cholesterol medications to antibiotics. By screening just a small library of A. nidulans natural products, we were able to identify three lead compounds capable of inhibiting tau aggregation. One of these, asperbenzaldehyde, represented a novel class of TAI. Because asperbenzaldehyde is a precursor to the chemical class of azaphilones, we subsequently generated and analyzed the TAI activity of 11 azaphilone derivatives in vitro. We found that all azaphilone derivatives tested inhibited tau aggregation. Four of the compounds also caused the disassembly of pre-formed filaments in a dose-dependent fashion by reducing both the length and number of tau filaments. Tau also retained significant microtubule-stabilization activity even in the presence of the most potent TAI, indicating that the azaphilone scaffold may be a very promising structural core for future development of tau therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Spine & Neurosurgery
  • SubjectNeuroscience & Neurology
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “T Chris Gamblin”
  • BylineArticles whose byline prints “S R Paranjape”
  • BylineArticles whose byline prints “Y M Chiang”
  • BylineArticles whose byline prints “C Wang”
  • BylineArticles whose byline prints “B R Oakley”
  • BylineArticles whose byline prints “T C Gamblin”